Jove
Visualize
Contact Us

Related Experiment Videos

Inflammation and Parkinson's disease.

Christophe Wersinger1, Anita Sidhu

  • 1Laboratory of Molecular Neurochemistry, Department of Pediatrics, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007, USA.

Current Drug Targets. Inflammation and Allergy
|October 17, 2003
PubMed
Summary

Inflammation and immune responses may play a role in the development and progression of Parkinson's disease (PD). This review examines evidence linking immune mechanisms to PD pathogenesis and compares it with other neurodegenerative disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway.

Brain research·2016
Same author

Transcriptional regulation of the α-synuclein gene in human brain tissue.

Neuroscience letters·2015
Same author

α-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease.

Neurobiology of disease·2015
Same author

Parallel mechanisms for direct and indirect membrane protein trafficking by synucleins.

Communicative & integrative biology·2014
Same author

Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.

PloS one·2013
Same author

Synucleins antagonize endoplasmic reticulum function to modulate dopamine transporter trafficking.

PloS one·2013
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Neuroinflammation is increasingly recognized in neurodegenerative diseases.
  • Immune system involvement can be a primary cause or secondary response to neuronal injury.
  • Evidence supports inflammatory mechanisms in Alzheimer's, Huntington's, MS, and other neurological conditions.

Purpose of the Study:

  • To review the role of inflammation and immune reactions in Parkinson's disease (PD).
  • To present clinical, epidemiological, and experimental data supporting immune involvement in PD.
  • To compare PD's immune aspects with other neurodegenerative disorders.

Main Methods:

  • Literature review of clinical, epidemiological, and experimental studies.
  • Examination of experimental models for studying neuroinflammation in PD.

Related Experiment Videos

  • Comparative analysis of PD with other neurodegenerative diseases.

    • Main Results:

    • Strong evidence suggests inflammation and immunity, potentially autoimmunity, are implicated in PD.
    • Immune mechanisms may contribute to both the onset and progression of Parkinson's disease.
    • Experimental models are crucial for understanding neuroinflammation's role in dopaminergic neuron degeneration.

    Conclusions:

    • Immune system dysregulation is a significant factor in Parkinson's disease.
    • Understanding neuroinflammation in PD offers insights into therapeutic strategies.
    • PD shares inflammatory pathways with other neurodegenerative conditions, yet has unique characteristics.